Psychedelic Drugs: Do You Need A Prescription For Medical Use?

• By Nick Dimengo
• February 4, 2021June 26, 2026
• medical psychedelics psychedelics
• With 1 comment

Last reviewed and updated: May 29, 2026.

Key Takeaways

Legal right now (U.S.)	Ketamine at licensed clinics (all states); psilocybin via licensed facilitators in Oregon and Colorado
MDMA status	FDA declined approval in 2024; appeal ongoing; available through clinical trials only
Ketamine: do you need a Rx?	Yes — clinics handle the evaluation and prescription in-house; no prior referral needed
Finding trials	ClinicalTrials.gov — search by substance or condition; major centers: Hopkins, NYU, UCSF
The big change since 2021	Psilocybin went from zero legal access to state-legal programs; ketamine exploded in availability; MDMA hit a regulatory wall

Psychedelic drugs are among the most promising new treatments of intractable mental health conditions: depression, end-of-life anxiety, addiction. They have also proven effective as therapeutic aids for milder mental health problems and even as tools for healthy people wishing to gain further insight into their own psyches.

Unfortunately, in the West, most of these drugs remain illegal. The United States has particularly stringent regulations on psychedelic drugs, with most being classified as Schedule I. While inconsistently enforced, penalties for sale and possession are high.

Psychedelic therapy thus remains out of reach for most. The one legal exception in the U.S. is ketamine. Some of the best ketamine therapy clinics are now in major urban areas, and may provide effective therapy for depression and other mental health issues. Responsible clinics require a formal diagnosis of the condition, and will prescribe a dosage off-label.

Those who wish to legally avail themselves of other psychedelic therapies involving magic mushrooms, LSD, MDMA, or ayahuasca will find themselves limited to government-approved research trials in most Western countries. (Search for psychedelic trials on ClinicalTrials.gov).

Legal Access Options Right Now

The legal landscape for psychedelic therapy has changed substantially since 2021. Here is the current state of legal access in the U.S. as of 2025.

Substance	Legal Status	How to Access
Ketamine	Schedule III — legal to prescribe	1,800+ U.S. clinics; esketamine (Spravato) FDA-approved for TRD
Psilocybin	Legal in Oregon and Colorado; decriminalized in several cities	Licensed facilitators in OR (2023+) and CO (2025+); clinical trials elsewhere
MDMA	Schedule I federally; FDA declined 2024, appeal ongoing	Clinical trials only (search ClinicalTrials.gov)
LSD, DMT, Ayahuasca	Schedule I federally; ayahuasca legal in some church contexts	Clinical trials; legal ayahuasca retreats abroad (Peru, Brazil, Netherlands)
Ibogaine	Schedule I in U.S.; legal in Mexico	Licensed ibogaine clinics in Mexico; clinical trials starting in U.S.

Successful trials have facilitated greater acceptance of these therapies. For example, four end-of-life patients gained access to psilocybin in Canada in 2020, along with 16 therapists. Still, they remain unavailable to most who are concerned about the legality of these drugs.

There are other options to be sure.

• Several American “churches” have used religious freedom laws to ensure that their members can consume ayahuasca legally.
• Underground ayahuasca retreats and psilocybin sessions have proliferated in the United States.
• A number of South American countries offer legal ayahuasca retreats.
• The Netherlands allows for the use of “truffle” — the mycelium or “root” from which psilocybin mushrooms grow.
• Mexico has established a number of ibogaine treatment centers. Check out Healing Maps’ list of some of Ketamine Clinics, Ibogaine Treatment Centers, and Ayahuasca Retreats.

Nonetheless, those looking to use these substances for therapeutic purposes must educate themselves about the side effects of medical psychedelics. Also, it’s important to know how these drugs may impact conditions in the absence of clinical observation. Many have reported positive effects, but there are a number of factors to keep in mind when venturing outside the boundaries of clinical medicine.

If Pursuing a Psychedelic Experience Outside a Clinical Setting

Regardless of your mental state, do some serious research before pursuing a psychedelic experience. This is particularly important if you are planning on using this experience to address a mental health condition.

Experts advise going to psychedelic seminars or meetups in your area. This will allow you to talk to people who are knowledgeable about the available arrangements. They can provide informed recommendations for underground sessions conducted by responsible guides in your city or direct you to reputable centers out of the country.

If possible, select a retreat run by medical professionals. They will be able to address any health concerns that arise during the experience. While most psychedelics are safe, people with cardiac conditions and other health problems may encounter problems such as elevated heart rate and body temperature.

Centers that feature trained shamans or guides are a reasonably safe alternative. These people have spent years facilitating psychedelic experiences. They also understand the powerful and sometimes disturbing sensory phenomena that may occur.

The most established and reliable networks in the West deal with ayahuasca, though underground groups also work with psilocybin mushrooms.

Substance Safety and Quality

Additionally, microdosing psychedelics may be another option. Consuming psychedelics in doses below those required to induce a psychedelic experience has proven effective in addressing some conditions. Still, these formulations available on the black market come without reliable quality controls.

Pursuing street drugs on your own is generally inadvisable. Substances such as MDMA are often adulterated with dangerous compounds. Even magic mushrooms bought from unknown sources may have LSD in them to amplify effects. Underground networks that take psychedelic drugs seriously can direct you to reliable sources, though even those should be treated with skepticism.

If traveling overseas, ensuring that your clinic is reliable and has good reviews is essential. A number of people who have attended psychedelic retreats in South America have encountered physical and sexual violence. Other clinics offer sub-par decoctions of the plants used in the preparation of ayahuasca and offer little in the way of guidance.

Integration: Why It Matters As Much As The Experience

Anecdotal reports testify to the profound effects psychedelic drugs can have on mental illness. Patients suffering from PTSD, depression, addiction, and other conditions claim miraculous remission of their symptoms after attending underground or overseas retreats. Clinical trials that have used psychedelics to treat these conditions verify some of their claims. Ketamine therapy for PTSD has shown promise, for example, but more research is necessary.

Patients seeking psychedelic treatment without medical supervision will need to take into account a number of other concerns. Clinical trials typically involve an element of psychotherapy that assists patients in processing their thoughts and feelings in the wake of a psychedelic trip. And well-run ayahuasca retreat uses either Western psychotherapy or shamanic ritual practice to help attendees work through the experience. The absence of these factors can significantly impact the outcome of these gonzo therapy sessions. Without structure, psychedelic experiences can be destabilizing and counterproductive.

Those who take psychedelic drugs in less-formal settings may benefit from legal counseling before and after their trips.

An increasing number of therapists offer pre- and post-experience counseling that assists patients in integrating psychedelic experiences into their lives. (The Center for Optimal Living offers resources for those looking to try psychedelic therapy. Institutes devoted to the study of psychedelic therapy may be able to connect you with appropriate therapists.)

By processing the strangeness of the psychedelic experience through an objective, clinical lens, patients can effectively leverage their altered mental state into sustainable change. This approach appears to be fully legal because the psychiatrists who provide these services do not actively provide drugs to their patients.

Who Should Not Use Psychedelics

Although more studies are needed, not all mental health issues mix well with psychedelics. It’s important to avoid treatment if the following is present.

• Avoid psychedelics if you have had psychotic breaks, symptoms of schizophrenia, bipolar disorder, or other similar psychiatric conditions.
• If you have heart problems, approach psychedelic use with extreme caution. These drugs can cause increases in heart rate.
• Do your research. Find centers and therapists endorsed by major advocacy organizations such as MAPS.
• Make sure that you find experiences that include an element of integration. Or ensure that you have external therapy sessions before and after taking psychedelics. While recreational users may be able to process unstructured psychedelic trips, those who wish to extract a therapeutic element will benefit immensely from counseling.

RELATED READING

• What Is Ketamine Therapy? Here’s What The Research Says
• Why Self-Medicating With Psychedelics Can Be Risky
• Find a Verified Ketamine Clinic Near You

Frequently Asked Questions

Do you need a prescription for ketamine therapy?

Yes — ketamine is a Schedule III controlled substance and requires a physician’s prescription. In practice, most ketamine clinics handle the evaluation and prescription in-house: you do an intake evaluation (usually combining a psychiatric assessment and a medical history review), and if cleared, the prescribing physician at the clinic orders the treatment. You don’t need a referral or a prior prescription, but you do need to be evaluated and cleared. Esketamine (Spravato) is FDA-approved and specifically requires administration in a certified healthcare provider setting — you take it on-site, not at home.

Is psilocybin therapy legal in the United States?

As of 2025, psilocybin facilitated sessions are legal in Oregon (since 2023 under Measure 109) and Colorado (under Proposition 122, with licensed facilitators beginning in 2025). Oregon does not require a psychiatric diagnosis — adults can access services through licensed facilitators at approved service centers. Federally, psilocybin remains Schedule I, but the state programs operate under a state-level exemption similar to how cannabis dispensaries work in states that have legalized it.

What happened with FDA approval of MDMA therapy?

In August 2024, the FDA declined to approve MDMA-assisted therapy (developed by MAPS as Lykos Therapeutics’ midomafetamine) for PTSD, citing concerns about the clinical trial data quality and the ability to maintain blinding in the trials. The agency requested an additional Phase 3 trial. MAPS/Lykos appealed the decision. MDMA-assisted therapy remains available only through clinical trials in the United States, though many researchers and clinicians consider it among the most promising PTSD treatments in development based on Phase 3 efficacy data showing 67% of patients no longer met PTSD diagnostic criteria after treatment.

How do I find a legitimate psychedelic therapy trial?

ClinicalTrials.gov is the authoritative U.S. registry for all ongoing clinical trials, including psychedelic research. Search for “psilocybin,” “MDMA,” “ketamine,” or the specific condition you’re dealing with. Major academic medical centers running psychedelic research include Johns Hopkins, NYU Langone, UCSF, and Imperial College London. The Multidisciplinary Association for Psychedelic Studies (MAPS) also maintains a trial registry. Many trials compensate participants and provide all substances, therapy, and follow-up at no cost.